IL-22, not simply a Th17 cytokine

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Interleukin-22 (IL-22) is a cytokine crucial for mucosal immunity and tissue repair.
• IL-22 uniquely acts on non-hematopoietic cells like epithelial cells, keratinocytes, and hepatocytes.
• While beneficial, IL-22 can be pathogenic, especially when co-released with IL-17, due to its pro-inflammatory nature.

Purpose of the Study:

• To review the production of IL-22 from diverse T-cell populations.
• To discuss the dual protective and pathogenic roles of IL-22.
• To highlight recent advancements in understanding IL-22's molecular regulation in T cells.

Main Methods:

• Literature review and synthesis of existing research on IL-22.
• Analysis of molecular pathways regulating IL-22 and IL-17 production.
• Discussion of transcription factors involved in cytokine expression.

Main Results:

• IL-22 production originates from various immune cells, including T-helper subsets and innate lymphocytes.
• Common factors (STAT3, RORγt) and specific factors (c-Maf) differentially regulate IL-22 and IL-17.
• Separate control of IL-22 and IL-17 production is essential to prevent pathology.

Conclusions:

• IL-22's function is context-dependent, requiring precise molecular regulation for beneficial outcomes.
• Understanding the distinct regulatory mechanisms of IL-22 and IL-17 is key to managing inflammatory and autoimmune diseases.
• Targeting specific molecular regulators offers potential therapeutic strategies for IL-22-mediated conditions.